PMC:7228307 / 4205-4361 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"49","span":{"begin":54,"end":58},"obj":"Gene"}],"attributes":[{"id":"A49","pred":"tao:has_database_id","subj":"49","obj":"Gene:2213"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"destructive effector responses by the inhibitory‐type FcγR, thereby avoiding injury to the host. Thus, therapeutic mAbs powerfully exploit these opposing ac"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T13","span":{"begin":77,"end":83},"obj":"Disease"}],"attributes":[{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"}],"text":"destructive effector responses by the inhibitory‐type FcγR, thereby avoiding injury to the host. Thus, therapeutic mAbs powerfully exploit these opposing ac"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T46","span":{"begin":54,"end":56},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"text":"destructive effector responses by the inhibitory‐type FcγR, thereby avoiding injury to the host. Thus, therapeutic mAbs powerfully exploit these opposing ac"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T12","span":{"begin":12,"end":20},"obj":"Chemical"}],"attributes":[{"id":"A12","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_35224"}],"text":"destructive effector responses by the inhibitory‐type FcγR, thereby avoiding injury to the host. Thus, therapeutic mAbs powerfully exploit these opposing ac"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T21","span":{"begin":91,"end":95},"obj":"http://purl.obolibrary.org/obo/IDO_0000531"}],"text":"destructive effector responses by the inhibitory‐type FcγR, thereby avoiding injury to the host. Thus, therapeutic mAbs powerfully exploit these opposing ac"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"49","span":{"begin":54,"end":58},"obj":"Gene"}],"attributes":[{"id":"A49","pred":"pubann:denotes","subj":"49","obj":"Gene:2213"}],"text":"destructive effector responses by the inhibitory‐type FcγR, thereby avoiding injury to the host. Thus, therapeutic mAbs powerfully exploit these opposing ac"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T10","span":{"begin":77,"end":83},"obj":"Disease"}],"attributes":[{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"}],"text":"destructive effector responses by the inhibitory‐type FcγR, thereby avoiding injury to the host. Thus, therapeutic mAbs powerfully exploit these opposing ac"}